20Med Therapeutics and Touchlight to collaborate on novel vaccine delivery platform project Published: 18 April 2023 Curia collaborates with Touchlight to expand its mRNA manufacturing offering to enable access to…
Read More
Touchlight secures government grant to support its £14m investment in scale-up DNA manufacturing Published: 29 March 2023 headline Hampton, UK, 29 March 2023 – Touchlight, a CDMO pioneering enzymatic DNA production…
Read More
Touchlight announces first FDA clearance of an IND utilising doggybone DNA Published: 28 February 2023 Enzymatic doggybone DNA material used in GMP production of a cell therapy by a US-based…
Read More
Touchlight signs license agreement with Voyager for use of Touchlight’s DNA technology in Voyager’s capsid discovery platform Published: 15 November 2022 Touchlight, an innovation-driven CDMO enabling the development of genetic…
Read More
Sarah Moore In this white paper, authored by Dr Sarah Moore, Head of Gene Therapy Discovery, Touchlight, we discuss major challenges and present approaches to improve overall functional titre, through…
Read More
Lonza and Touchlight collaborate on end-to-end mRNA offering Published: 6 September 2022 Collaboration expands Lonza’s end-to-end offering for mRNA manufacturing with additional, differentiated source of DNA raw material, Touchlight’s doggybone…
Read More
Satish Muchakayala Antimicrobial resistance (AMR) is a global health threat and a complex problem that requires a united multisectoral approach. In the interest of patients and environmental safety, regulators around…
Read More
Touchlight signs patent license agreement with Pfizer for the use of dbDNA for the manufacture of mRNA-based vaccines, therapeutics and gene therapies Published: 6 July 2022 Pfizer and Touchlight agree to patent license…
Read More
SARAH MOORE & MARIA BARREIRA With contribution by Helen Horton and Claire KerridgeTraditional bacterial fermentation techniques used to manufacture plasmid are time-consuming, expensive, and inherently unstable. The production of sufficient…
Read More
AskBio and Touchlight Restructure Joint Venture Published: 8 February 2022 Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, and Touchlight,…
Read More
